Hematopoiesis


Hematopoiesis is the term applied to the myriad processes resulting in blood cell production. The description of hematopoietic stem cell activity stands as a tremendous scientific milestone of the last century and was a culmination of many studies. Moreover, the detailed analysis of hematopoiesis also directly facilitated the development of a profoundly beneficial medical intervention, namely bone marrow transplantation, a stunning example of the key role that basic research plays in improving human health.

Our laboratory has a keen interest in understanding the process of hematopoiesis at all levels including the specification of blood tissue in the developing embryo and mechanisms contributing to efficient transplantation of blood-forming activity. Our work in hematopoiesis bridges our interests in

PLURIPOTENT CELL BIOLOGY

and

CANCER THERAPEUITICS

with projects in the derivation and engraftment of lympho/myeloid repopulating activity from an ES cell starting point as well as the study of disease-specific stem cells in the context of blood formation.

A composite depicting key events in hematopoiesis in vivo for the mouse (on top and scaled in days) and human (on bottom and scaled in weeks). Both murine and human figures are interpreted using the same key as follows: vertical red dashed line at left, onset of circulation; vertical green solid line at right, birth; EryP, primitive nucleated erythroblasts in peripheral blood (PB); EryD, definitive anucleate erthrythrocytes in PB; P-Sp, onset of hematopoiesis in the paraaortic splanchnopleura (down-slanting hash marks); AGM, onset of hematopoiesis in aorta-gonad-mesonephros (up-slanting hash marks); blue horizontal bars, alpha-like globin gene expression; black horizontal bars, beta-like globin expression; yellow area, yolk sac hematopoiesis; green area, transition from yolk sac to liver; blue area, liver hematopoiesis; purple area, transition from liver to bone marrow; red area, bone marrow hematopoiesis. taken from Lensch and Daley, Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models. Curr Top Dev Biol. 2004;60:127-96.

The process of hematopoietic cell formation from ES cells as well as the scale of the intermediates generated therein. (A) A mouse (line CCE) embryoid body at day 14 of culture. Several prominent blood islands may be noted. EB's are then disrupted and replated in coculture with stromal cell underlayers. Following coculture, hematopoietic precursors are replated into methylcellulose that contains hematopoietic growth factors in order to determine (retrospectively) the progenitor content of the input material. (B) A typical day 10 colony-forming unit granulocyte, erythrocyte, macrophage, and megakaryocyte (CFU-GEMM). (C) A composite of representative myeloid cell types found in CFU-GEMM following staining with W/G. taken from Lensch and Daley, Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models. Curr Top Dev Biol. 2004;60:127-96. Effect of Doxycycline Induction of HoxB4 on EB Cells in vitro (A) Colony formation by cells from day 6 EB controls, and day 6 EBs treated with doxycycline from day 4 to day 6, in hematopoietic methylcellulose suspension culture. HPP-GEMM refers to dense GEMMs not normally seen at day 6 of EB development. (B) Morphology of a typical day 6 GEMM. (C) Morphology of a doxycycline-induced HPP-GEMM at the same magnification as in (B). (D) A colony of semiadherent cells from HoxB4-induced day 6 EB cells plated on OP9 in the presence of doxycycline. (E) Cytospin preparation of these cells growing on OP9. (F) Colony-forming activity of doxycycline-induced cells grown on OP9 in methylcellulose with myeloid cytokines. Control indicates doxycycline not added to methylcellulose cultures; +dox indicates doxycycline induction maintained during methylcellulose culture. (G) Cytospin preparation from a GEMM obtained from cultures described in (F). Open arrowheads show erythroblasts; filled arrowhead shows megakaryocyte. taken from Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell. 2002 Apr 5;109(1):29-37.
Fig. 5. Clonal analysis of hematopoietic populations of mice engrafted with ESC-derived HSCs, as determined by Southern hybridization analysis of retroviral integration sites. (A) Structure of the retroviral vector MSCV-HoxB4-ires-GFP. Probes used in Southern hybridization analysis are indicated. (B Left) Southern analysis of fractionated myeloid and lymphoid populations from primary (1ry) and unrelated secondary (2ry) engrafted mice, showing multiple comigrating fragments. (B Right) Bone marrow and spleen cells from two primary engrafted animals and comparable tissue from the corresponding secondary animals, showing comigrating fragments. (C) Southern analysis of hematopoietic tissues from one primary and two corresponding secondary recipients engrafted with ESC-HSCs: spleen (S), BM (B), Gr1+ BM cells (B/G), Gr1+ splenocytes (S/G), and CD3+ or B220+ splenic lymphocytes (S/L). Mye/Lym represents the ratio of Gr-1+ cells to CD3+ and B220+ populations in corresponding sample, as determined by flow cytometry. Relative DNA level was calculated by comparing endogenous HoxB4 (endog) with control (DNA isolated from Ainv15 ES cells). Proviral copy number was calculated by comparing the level of proviral HoxB4 (Rv-HoxB4) with endogenous HoxB4 level. Samples reflect Cdx4/HoxB4-engrafted cells, except the third and fourth lanes in B Left, which represent HoxB4-treated cells. #, fragments detected only in primary recipients; *, fragments unique to secondary engrafted animals; ^, fragments detected predominantly in one lineage. taken from Wang, Yates, Naveiras, Ernst, and Daley. Embryonic stem cell-derived hematopoietic stem cells. PNAS December 27, 2005 vol. 102 no. 52 19081-19086. go to abstract online
Return to Daley Lab Homepage